Imagine waiting in line for a new ride at an amusement park, anxious and excited. You finally get on the ride, and to your surprise, the thrilling experience starts right away! That’s exactly what Axsome Therapeutics’ newly FDA-approved drug is like for adults with depression. With its oral form, this medication aims to provide relief in just one week, offering a faster solution than traditional treatments. The FDA’s approval is a big win for the company after facing a delay last year. This groundbreaking drug could potentially revolutionize the way we treat depression, opening doors to improved mental health and well-being. Now, individuals struggling with depression have a ray of hope shining down on them! If you or someone you know is affected by depression, it’s worth exploring this exciting advancement in pharmaceutical research.
Axsome Therapeutics Inc said on Friday the U.S. Food and Drug Administration approved its oral drug for the treatment of depression in adults, sending its shares up 17% in premarket trading. The company faced a delay in getting the agency’s approval for the drug last year…
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.